doi: 10.1016/j.jad.2018.04.042
SGLT-2i, sodium-glucose cotransporter-2 inhibitor Conclusion In conclusion, there are no randomized controlled trials studying the use of GLP-1 RAs as a treatment of cirrhosis, and current data supporting the use comes from retrospective studies
Your choice between NAD+ vs glutathione mostly depends on your health goals and needs
Frontal glutamate and -aminobutyric acid levels and their associations with mismatch negativity and digit sequencing task performance in schizophrenia
Martina V, Masha A, Gigliardi VR, Brocato L, Manzato E, Berchio A, Massarenti P, Settanni F, Della Casa L, Bergamini S, Iannone A